• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体作为角膜疾病未来的治疗工具和靶点

Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases.

作者信息

Gamez Joshua, Zha Daxian, Ebrahimi Shaghaiegh M, White Seok, Ljubimov Alexander V, Saghizadeh Mehrnoosh

机构信息

Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

Cells. 2025 Jun 23;14(13):959. doi: 10.3390/cells14130959.

DOI:10.3390/cells14130959
PMID:40643480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12248451/
Abstract

The therapeutic potential of exosomes (Exos), a subpopulation of extracellular vesicles (EVs) secreted by various cell types, has been broadly emphasized. Exos are endosome-derived membrane-bound vesicles 50-150 nm in size. Exos can be general or cell type-specific. Their contents enable them to function as multi-signaling and vectorized vehicles. Exos are important for maintaining cellular homeostasis. They are released into extracellular spaces, leading to uptake by neighboring or distant cells and delivering their contents to modulate cell signaling. Exos influence tissue responses to injury, infection, and disease by fusion with the target cells and transferring their cargo, including cytokines, growth and angiogenic factors, signaling molecules, lipids, DNA, mRNAs, and non-coding RNAs. They are implicated in various physiological and pathological conditions, including ocular surface events, such as corneal scarring, wound healing, and inflammation. Their biocompatibility, stability, low immunogenicity, and easy detectability in bodily fluids (blood, tears, saliva, and urine) make them promising tools for diagnosing and treating ocular diseases. The potential to engineer specific Exo cargos makes them outstanding therapeutic delivery vehicles. The objective of this review is to provide novel insights into the functions of Exo cargos and their applications as biomarkers and therapeutics, or targets in the cornea.

摘要

外泌体(Exos)是由多种细胞类型分泌的细胞外囊泡(EVs)亚群,其治疗潜力已得到广泛强调。外泌体是源自内体的膜结合囊泡,大小为50-150纳米。外泌体可以是通用的或细胞类型特异性的。它们的内容物使它们能够作为多信号和载体化的媒介发挥作用。外泌体对于维持细胞内稳态很重要。它们被释放到细胞外空间,导致邻近或远处的细胞摄取,并传递其内容物以调节细胞信号传导。外泌体通过与靶细胞融合并转移其货物,包括细胞因子、生长和血管生成因子、信号分子、脂质、DNA、mRNA和非编码RNA,影响组织对损伤、感染和疾病的反应。它们参与各种生理和病理状况,包括眼表事件,如角膜瘢痕形成、伤口愈合和炎症。它们的生物相容性、稳定性、低免疫原性以及在体液(血液、眼泪、唾液和尿液)中易于检测,使其成为诊断和治疗眼部疾病的有前途的工具。设计特定外泌体货物的潜力使其成为出色的治疗递送载体。本综述的目的是提供关于外泌体货物的功能及其作为生物标志物和治疗剂或角膜靶点的应用的新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce4/12248451/73f0d55b5f73/cells-14-00959-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce4/12248451/6ed4e19a829f/cells-14-00959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce4/12248451/58003bbbef4d/cells-14-00959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce4/12248451/73f0d55b5f73/cells-14-00959-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce4/12248451/6ed4e19a829f/cells-14-00959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce4/12248451/58003bbbef4d/cells-14-00959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce4/12248451/73f0d55b5f73/cells-14-00959-g003.jpg

相似文献

1
Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases.外泌体作为角膜疾病未来的治疗工具和靶点
Cells. 2025 Jun 23;14(13):959. doi: 10.3390/cells14130959.
2
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
3
Brain-derived extracellular vesicles: A promising avenue for Parkinson's disease pathogenesis, diagnosis, and treatment.脑源性细胞外囊泡:帕金森病发病机制、诊断和治疗的一条有前景的途径。
Neural Regen Res. 2025 Apr 29. doi: 10.4103/NRR.NRR-D-24-01262.
4
Role of Exosome in Solid Cancer Progression and Its Potential Therapeutics in Cancer Treatment.外泌体在实体癌进展中的作用及其在癌症治疗中的潜在疗法
Cancer Med. 2025 May;14(9):e70941. doi: 10.1002/cam4.70941.
5
Defining the Parameters for Sorting of RNA Cargo Into Extracellular Vesicles.定义RNA货物分选到细胞外囊泡中的参数。
J Extracell Vesicles. 2025 Jul;14(7):e70113. doi: 10.1002/jev2.70113.
6
TGF-β-Based Therapies for Treating Ocular Surface Disorders.基于 TGF-β 的眼表疾病治疗方法。
Cells. 2024 Jun 26;13(13):1105. doi: 10.3390/cells13131105.
7
Short-Term Memory Impairment短期记忆障碍
8
Exosome-Based Therapy in Cardiovascular Diseases: A New Frontier in Cardiovascular Disease Treatment.基于外泌体的心血管疾病治疗:心血管疾病治疗的新前沿
Korean Circ J. 2025 Mar 5. doi: 10.4070/kcj.2025.0022.
9
Exosome-based mucosal therapeutic and diagnostic system: towards clinical translation.基于外泌体的黏膜治疗与诊断系统:迈向临床转化
J Control Release. 2025 Jun 17;385:113966. doi: 10.1016/j.jconrel.2025.113966.
10
Exosomes in neurodegenerative diseases: Therapeutic potential and modification methods.神经退行性疾病中的外泌体:治疗潜力与修饰方法。
Neural Regen Res. 2026 Feb 1;21(2):478-490. doi: 10.4103/NRR.NRR-D-24-00720. Epub 2024 Oct 22.

本文引用的文献

1
Therapeutic Potential of Umbilical Cord MSC-Derived Exosomes in a Severe Dry Eye Rat Model: Enhancing Corneal Protection and Modulating Inflammation.脐带间充质干细胞衍生外泌体在严重干眼大鼠模型中的治疗潜力:增强角膜保护和调节炎症
Biomedicines. 2025 May 11;13(5):1174. doi: 10.3390/biomedicines13051174.
2
Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors.用于高效细胞内递送包括基因组编辑器在内的多模式治疗剂的细胞外囊泡工程。
Nat Commun. 2025 Apr 29;16(1):4028. doi: 10.1038/s41467-025-59377-y.
3
Proteomic Insights into Human Limbal Epithelial Progenitor-Derived Small Extracellular Vesicles.
对人角膜缘上皮祖细胞来源的小细胞外囊泡的蛋白质组学见解
Stem Cell Rev Rep. 2025 Apr 16. doi: 10.1007/s12015-025-10877-w.
4
Corneal stromal cells from patients with keratoconus exhibit alterations in the ESCRT-dependent machinery responsible for multivesicular body formation.圆锥角膜患者的角膜基质细胞在负责多囊泡体形成的内体分选转运复合体(ESCRT)依赖性机制中表现出改变。
Exp Eye Res. 2025 Mar;252:110260. doi: 10.1016/j.exer.2025.110260. Epub 2025 Jan 30.
5
Application of stem cell-derived exosomes in anterior segment eye diseases: A comprehensive update review.干细胞衍生外泌体在前节眼部疾病中的应用:全面更新综述
Ocul Surf. 2025 Apr;36:209-219. doi: 10.1016/j.jtos.2025.01.012. Epub 2025 Jan 28.
6
Regulation of corneal epithelial differentiation: miR-141-3p promotes the arrest of cell proliferation and enhances the expression of terminal phenotype.角膜上皮分化的调控:miR-141-3p促进细胞增殖停滞并增强终末表型的表达。
PLoS One. 2024 Dec 6;19(12):e0315296. doi: 10.1371/journal.pone.0315296. eCollection 2024.
7
Corneal Treatment, Repair, and Regeneration: Exosomes at Rescue.角膜治疗、修复与再生:外泌体来救援。
Pharmaceutics. 2024 Nov 7;16(11):1424. doi: 10.3390/pharmaceutics16111424.
8
The urgent need for clear and concise regulations on exosome-based interventions.迫切需要制定明确和简洁的基于外泌体的干预措施法规。
Stem Cell Reports. 2024 Nov 12;19(11):1517-1519. doi: 10.1016/j.stemcr.2024.09.008. Epub 2024 Oct 24.
9
Target specification and therapeutic potential of extracellular vesicles for regulating corneal angiogenesis, lymphangiogenesis, and nerve repair.用于调节角膜血管生成、淋巴管生成和神经修复的细胞外囊泡的靶点特性及治疗潜力
Ocul Surf. 2024 Oct;34:459-476. doi: 10.1016/j.jtos.2024.10.005. Epub 2024 Oct 18.
10
Mesenchymal Stem Cells-Derived Exosomal miR-223-3p Alleviates Ocular Surface Damage and Inflammation by Downregulating Fbxw7 in Dry Eye Models.间充质干细胞衍生的外泌体 miR-223-3p 通过下调干燥模型中的 Fbxw7 缓解眼表面损伤和炎症。
Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):1. doi: 10.1167/iovs.65.12.1.